Subclasses of platelet 3H-imipramine binding sites
- PMID: 1963692
- DOI: 10.1016/0165-1781(90)90007-r
Subclasses of platelet 3H-imipramine binding sites
Abstract
The possible presence of multiple high affinity 3H-imipramine (3H-IMI) binding sites on blood platelets was studied using trypsin digestion and cyanoimipramine (CNIMI), a pseudo-irreversible inhibitor of 3H-IMI binding and serotonin uptake. Increasing concentrations of CNIMI resulted in a discontinuous curve with a plateau at intermediate concentrations (0.05-0.35 nM). CNIMI sensitive (0.25 nM) sites accounted for approximately half of total high affinity 3H-IMI binding as defined by displacement with 100 microM desipramine. Similar results were obtained when platelet membranes were pretreated with trypsin (0.21-0.84 mg/ml), and no additional inhibition was evident with a combination of both treatments. The present results suggest that 3H-IMI may bind to two separate types of high affinity sites. One subclass is apparently proteinaceous and sensitive to low concentrations of CNIMI, whereas the other is apparently nonproteinaceous and is CNIMI resistant.
Similar articles
-
Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression.Psychiatry Res. 1990 Dec;34(3):315-29. doi: 10.1016/0165-1781(90)90009-t. Psychiatry Res. 1990. PMID: 1963694
-
Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol.Psychiatry Res. 1990 Dec;34(3):303-13. doi: 10.1016/0165-1781(90)90008-s. Psychiatry Res. 1990. PMID: 1963693
-
Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).Eur J Pharmacol. 1985 Feb 12;109(1):97-104. doi: 10.1016/0014-2999(85)90544-8. Eur J Pharmacol. 1985. PMID: 2986992
-
Imipramine binding sites in brain and platelets: role in affective disorders.Int J Clin Pharmacol Res. 1989;9(2):119-22. Int J Clin Pharmacol Res. 1989. PMID: 2541089 Review.
-
WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study.Pharmacopsychiatry. 1988 May;21(3):147-50. doi: 10.1055/s-2007-1014667. Pharmacopsychiatry. 1988. PMID: 2841696 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources